Urea 41% Cream

Manufacturer
Bowyn Labs, LLC
Effective date
2018-04-12
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-02 00:59:59

Label at a glance#

ProductUrea
Active ingredientUREA
Label structure11 sections

Dosage and administration

Apply to affected area(s) twice per day or as directed by a physician. Rub in until completely absorbed.

Storage and handling

Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (between 59°F to 86°F). Brief exposure to temperatures up to 40°C (104°F) may be tolerated provided the mean kinetic temperature does not exceed 25°C (77°F); however, such exposure should be minimized. NOTICE: Protect from freezing and excessive heat. The product may tend to darken in color on storage. The discoloration does not impair...

Label contents#

Full prescribing information#

DESCRIPTION:

DESCRIPTION SECTION

Each gram contains 410 mg of urea in a vehicle consisting of: carbomer, cetyl alcohol, glyceryl stearate, mineral oil, petrolatum, propylene glycol, sodium hydroxide, water and xanthan gum.

Urea is a diamide of carbonic acid with the following chemical structure:

structurestructure

CLINICAL PHARMACOLOGY:

CLINICAL PHARMACOLOGY SECTION

Urea gently dissolves the intercellular matrix which results in loosening the horny layer of skin and shedding scaly skin at regular intervals, thereby softening hyperkeratotic areas of the skin.

Pharmacokinetics: The mechanism of action of topically applied urea is not yet known.

INDICATIONS:

INDICATIONS & USAGE SECTION

This product is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, xerosis, ichthyosis, skin cracks and fissures, dermatitis, eczema, psoriasis, keratoses and calluses.

CONTRAINDICATIONS:

CONTRAINDICATIONS SECTION

This product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product.

WARNINGS:

WARNINGS SECTION

KEEP OUT OF REACH OF CHILDREN.

PRECAUTIONS:

PRECAUTIONS SECTION

FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE.

General: This product is to be used as directed by a physician and should not be used to treat any condition other than that for which it was prescribed. If redness or irritation occurs, discontinue use and consult a physician.

Information for Patients: Patients should discontinue the use of this product if the condition becomes worse or if a rash develops in the area being treated or elsewhere. Avoid contact with eyes, lips and mucous membranes.

Carcinogenesis, Mutagenesis and Impairment of Fertility: Long-term animal studies for carcinogenic potential have not been performed on this product to date. Studies on reproduction and fertility also have not been performed.

Pregnancy:Category C. Animal reproduction studies have not been conducted with this product. It is also not known whether this product can affect reproduction capacity or cause fetal harm when administered to a pregnant woman. This product should be used by a pregnant woman only if clearly needed or when potential benefits outweigh potential hazards to the fetus.

Nursing Mothers: It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when this product is administered to a nursing woman.

ADVERSE REACTIONS:

ADVERSE REACTIONS SECTION

Transient stinging, burning, itching or irritation may occur and normally disappear upon discontinuing the use of this product.

DOSAGE AND ADMINISTRATION:

DOSAGE & ADMINISTRATION SECTION

Apply to affected area(s) twice per day or as directed by a physician. Rub in until completely absorbed.

STORAGE:

STORAGE AND HANDLING SECTION

Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (between 59°F to 86°F). Brief exposure to temperatures up to 40°C (104°F) may be tolerated provided the mean kinetic temperature does not exceed 25°C (77°F); however, such exposure should be minimized.

NOTICE: Protect from freezing and excessive heat. The product may tend to darken in color on storage. The discoloration does not impair the efficacy or safety of the product. Keep bottle tightly closed.

HOW SUPPLIED:

HOW SUPPLIED SECTION

This product is supplied in the following size(s):

8 oz. (227 g) bottles, NDC 52191-351-08

To report a serious adverse event or obtain product information, call 1-855-899-4237.

Manufactured for:
Bowyn Labs, LLC
13785 Research Blvd.
Suite 125
Austin, TX 78750

828003 v1 Rev. 04/2018

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

label.jpglabel.jpg

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
52191-351-08GM - Gram52191-351a7affc9d-aab0-4e6e-be08-e1c0ff3ab75012018-05-09

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 1 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
52191-35152191-351-08

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 1 matching rows.

Name, UNII, Kind table
NameUNIIKind
UREA8W8T17847WACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
c24c15e3-0489-0cee-e053-2995a90a3e4d69ac5657-d5b2-1abc-e053-2991aa0a26d72021-05-14Warnings, Adverse reactionsExact identifier
spl set id: 69ac5657-d5b2-1abc-e053-2991aa0a26d7

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.